Interactive Tools

Trending on OncLive

Sac-TMT Improves PFS and OS, Is Under FDA Priority Review in Previously Treated Endometrial Cancer

KEYNOTE-C93 Shows PFS Benefit With First-Line Pembrolizumab Monotherapy in dMMR Endometrial Cancer

Rinatabart Sesutecan Improves Survival in Platinum-Resistant Ovarian Cancer

Early ctDNA Clearance Linked to Improved Survival With Pembrolizumab Regimen in HPV-Negative HNSCC

Extended DeLLphi-304 Follow-Up Confirms Durable Survival Benefit With Tarlatamab in Previously Treated SCLC